
Genetic Technologies Limited GENE
Quartalsbericht 2024-Q2
hinzugefügt 23.05.2026
Genetic Technologies Limited P/CF 2011-2026 | GENE
P/CF Jährlich Genetic Technologies Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -23.5 | -2.81 K | -3.18 K | -1.21 K | -1.49 K | -1.78 K | -977 | -2.47 | -1.58 | -5.3 | -7.43 | 38.9 |
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 38.9 | -3.18 K | -954 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Agilent Technologies
A
|
28.3 | $ 135.53 | 0.11 % | $ 41.2 B | ||
|
Celcuity
CELC
|
-35 | $ 132.88 | 1.5 % | $ 6.21 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 8.53 | -23.77 % | $ 11.3 M | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 21.08 | -4.66 % | $ 611 M | ||
|
Aspira Women's Health
AWH
|
-0.0975 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0826 | - | -61.36 % | $ 2.46 M | ||
|
Fulgent Genetics
FLGT
|
-5.18 | $ 18.14 | -0.55 % | $ 558 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
-72.7 | $ 129.69 | -2.65 % | $ 16.3 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 22.82 | 0.53 % | $ 1.22 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
9.76 | $ 136.07 | -0.53 % | $ 10.7 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.7 | -5.56 % | $ 7.52 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
19.6 | $ 162.96 | 2.68 % | $ 25.9 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 99.3 | -0.32 % | $ 6.7 B | ||
|
Global Cord Blood Corporation
CO
|
0.495 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 180.58 | 1.47 % | $ 24.3 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 180.71 | -0.35 % | $ 8.96 B | ||
|
NeoGenomics
NEO
|
284 | $ 10.52 | 3.24 % | $ 1.35 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
National Research Corporation
NRC
|
11.9 | $ 19.53 | -0.66 % | $ 437 M | ||
|
Natera
NTRA
|
-12.3 | $ 223.37 | 4.41 % | $ 22 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 447.11 | -0.23 % | $ 12.9 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 3.97 | -5.92 % | $ 368 M | ||
|
Personalis
PSNL
|
-5.75 | $ 11.4 | 3.83 % | $ 1.02 B | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 26.39 | -0.23 % | $ 25 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.79 | 1.04 % | $ 283 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | - | - | $ 2.69 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 66.87 | -3.13 % | $ 4 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.39 | -1.74 % | $ 5.49 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 260.06 | -0.75 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 492.51 | 1.09 % | $ 186 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.7 | -0.16 % | $ 251 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 8.97 | -3.55 % | $ 1.95 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 194.9 | -0.72 % | $ 21.6 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M |